You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: August 14, 2024

SHADE UVAGUARD Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Shade Uvaguard patents expire, and what generic alternatives are available?

Shade Uvaguard is a drug marketed by Bayer Healthcare Llc and is included in one NDA.

The generic ingredient in SHADE UVAGUARD is avobenzone; octinoxate; oxybenzone. There are two drug master file entries for this compound. Additional details are available on the avobenzone; octinoxate; oxybenzone profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SHADE UVAGUARD?
  • What are the global sales for SHADE UVAGUARD?
  • What is Average Wholesale Price for SHADE UVAGUARD?
Summary for SHADE UVAGUARD
Drug patent expirations by year for SHADE UVAGUARD

US Patents and Regulatory Information for SHADE UVAGUARD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc SHADE UVAGUARD avobenzone; octinoxate; oxybenzone LOTION;TOPICAL 020045-001 Dec 7, 1992 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for SHADE UVAGUARD

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Healthcare Llc SHADE UVAGUARD avobenzone; octinoxate; oxybenzone LOTION;TOPICAL 020045-001 Dec 7, 1992 ⤷  Sign Up ⤷  Sign Up
Bayer Healthcare Llc SHADE UVAGUARD avobenzone; octinoxate; oxybenzone LOTION;TOPICAL 020045-001 Dec 7, 1992 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for SHADE UVAGUARD

See the table below for patents covering SHADE UVAGUARD around the world.

Country Patent Number Title Estimated Expiration
Brazil 8300337 ⤷  Sign Up
Germany 2945125 ⤷  Sign Up
European Patent Office 0085334 ⤷  Sign Up
Netherlands 190101 ⤷  Sign Up
Japan S58128315 EXTERNAL COMPOSITION HAVING PERPETUITY ⤷  Sign Up
Australia 1071983 ⤷  Sign Up
Canada 1196577 COMPOSITIONS TOPIQUES TRES EFFICACES (SUBSTANTIVE TOPICAL COMPOSITIONS) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.